Updates from The Motley Fool

Latest updates on Myriad Genetics from Fool.com.

Stock Performance

MYGN vs. S&P 500 | 2 Year Performance
MYGN 1-Day Stock Chart
MYGN 5-Day Stock Chart
MYGN 1-Month Stock Chart
MYGN 3-Month Stock Chart
MYGN 6-Month Stock Chart
MYGN 1-Year Stock Chart
MYGN 2-Year Stock Chart
MYGN 5-Year Stock Chart
View Interactive MYGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Myriad Genetics.
Current Price: $34.09
Prev Close: $33.43
Open: $33.50
Bid: $32.81
Ask: $34.79
Day's Range: $33.45 - $34.45
52wk Range: $30.30 - $46.24
Volume: 855,284
Avg Vol 906,439
Market Cap: $2.38B
P/E (ttm): 22.59
EPS (ttm): $1.48
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Myriad Genetics.
CAPS Rating 3 out of 5
522 Outperform
91 Underperform
CAPS All Stars
112 Outperform
15 Underperform

How do you think Myriad Genetics will perform against the market?

You pick for Myriad Genetics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark C. Capone, CEO

100% Approve

Based on 14 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Myriad Genetics.

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Diversified Services